IRVIX | VIVIX | IRVIX / VIVIX | |
Total Expense Ratio | 0.34 | 0.04 | 850% |
Annual Report Gross Expense Ratio | 0.44 | 0.04 | 1,100% |
Fund Existence | 16 years | 27 years | - |
Gain YTD | -16.144 | 2.452 | -658% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 266M | 189B | 0% |
Annual Yield % from dividends | 7.76 | 2.29 | 339% |
Returns for 1 year | -9.73 | 8.01 | -121% |
Returns for 3 years | 12.44 | 32.19 | 39% |
Returns for 5 years | 44.50 | 72.56 | 61% |
Returns for 10 years | 60.79 | 103.54 | 59% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
THOCX | 39.63 | -0.44 | -1.10% |
Thornburg Global Opportunities C | |||
ODIIX | 123.03 | -1.91 | -1.53% |
Invesco Discovery R6 | |||
MSQLX | 11.24 | -0.20 | -1.75% |
Morgan Stanley Inst International Eq L | |||
RYWCX | 37.68 | -0.71 | -1.85% |
Rydex S&P SmallCap 600 Pure Growth C | |||
ASQCX | 13.50 | -0.27 | -1.96% |
American Century Small Company C |